MicroRNA-144 is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related a Disintegrin and Metalloprotease 10 (ADAM10)

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Apr 3

PMID 23546882

Citations 63

Authors

Cong Cheng

Weiguang Li

Zheng Zhang

Shohei Yoshimura

Qinyu Hao

Chi Zhang

Zhao Wang

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNA (miR) dysregulation is found in Alzheimer disease (AD). A disintegrin and metalloprotease 10 (ADAM10) prevents generation of amyloid β (Aβ) and decrease AD pathology.

Results: miR-144 suppresses ADAM10 expression and is up-regulated by activator protein-1.

Conclusion: miR-144 is a negative regulator of ADAM10 and may be involved in AD pathogenesis.

Significance: The first work to demonstrate the function of miRNA-144 and its regulation in the pathogenesis of AD. Amyloid β-peptide (Aβ) accumulating in the brain of Alzheimer disease (AD) patients is believed to be the main pathophysiologcal cause of the disease. Proteolytic processing of the amyloid precursor protein by α-secretase ADAM10 (a disintegrin and metalloprotease 10) protects the brain from the production of the Aβ. Meanwhile, dysregulation or aberrant expression of microRNAs (miRNAs) has been widely documented in AD patients. In this study, we demonstrated that overexpression of miR-144, which was previously reported to be increased in elderly primate brains and AD patients, significantly decreased activity of the luciferase reporter containing the ADAM10 3'-untranslated region (3'-UTR) and suppressed the ADAM10 protein level, whereas the miR-144 inhibitor led to an increase of the luciferase activity. The negative regulation caused by miR-144 was strictly dependent on the binding of the miRNA to its recognition element in the ADAM10 3'-UTR. Moreover, we also showed that activator protein-1 regulates the transcription of miR-144 and the up-regulation of miR-144 at least partially induces the suppression of the ADAM10 protein in the presence of Aβ. In addition, we found that miR-451, a miRNA processed from a single gene locus with miR-144, is also involved in the regulation of ADAM10 expression. Taken together, our data therefore demonstrate miR-144/451 is a negative regulator of the ADAM10 protein and suggest a mechanistic role for miR-144/451 in AD pathogenesis.

Citing Articles

An Update on Neuroaging on Earth and in Spaceflight.

Kuznetsov N, Statsenko Y, Ljubisavljevic M Int J Mol Sci. 2025; 26(4).

PMID: 40004201 PMC: 11855577. DOI: 10.3390/ijms26041738.

miR-32533 Reduces Cognitive Impairment and Amyloid-β Overload by Targeting CREB5-Mediated Signaling Pathways in Alzheimer's Disease.

Zeng L, Cai Z, Liu J, Zhao K, Liang F, Sun T Adv Sci (Weinh). 2025; 12(10):e2409986.

PMID: 39840513 PMC: 11905094. DOI: 10.1002/advs.202409986.

Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review.

Peng L, Zhang Z, Li Q, Song Z, Yan C, Ling H Heliyon. 2024; 10(20):e39217.

PMID: 39629139 PMC: 11612466. DOI: 10.1016/j.heliyon.2024.e39217.

Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer's Diseases.

Duan X, Zheng Q, Liang L, Zhou L Degener Neurol Neuromuscul Dis. 2024; 14:21-31.

PMID: 38618193 PMC: 11012623. DOI: 10.2147/DNND.S444567.

miR-3940-5p reduces amyloid β production via selectively targeting .

Qi Y, Wang X, Guo X Front Aging Neurosci. 2024; 16:1346978.

PMID: 38501059 PMC: 10944889. DOI: 10.3389/fnagi.2024.1346978.

References

de la Monte S . Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2012; 9(1):35-66. PMC: 3349985. DOI: 10.2174/156720512799015037. View

Lee S, Doberstein K, Baumgarten P, Wieland A, Ungerer C, Burger C . PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells. PLoS One. 2011; 6(8):e22312. PMC: 3158060. DOI: 10.1371/journal.pone.0022312. View

Angel P, Imagawa M, Chiu R, Stein B, Imbra R, Rahmsdorf H . Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 1987; 49(6):729-39. DOI: 10.1016/0092-8674(87)90611-8. View

Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M . Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A. 1999; 96(7):3922-7. PMC: 22396. DOI: 10.1073/pnas.96.7.3922. View

Conaco C, Otto S, Han J, Mandel G . Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A. 2006; 103(7):2422-7. PMC: 1413753. DOI: 10.1073/pnas.0511041103. View

Lee W, Mitchell P, Tjian R . Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 1987; 49(6):741-52. DOI: 10.1016/0092-8674(87)90612-x. View

Tanzi R, Bertram L . Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005; 120(4):545-55. DOI: 10.1016/j.cell.2005.02.008. View

Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L . miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep. 2012; 27(5):1660-8. DOI: 10.3892/or.2012.1682. View

Yankner B . A century of cognitive decline. Nature. 2000; 404(6774):125. DOI: 10.1038/35004673. View

10.

Rauscher 3rd F, Voulalas P, Franza Jr B, Curran T . Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 1988; 2(12B):1687-99. DOI: 10.1101/gad.2.12b.1687. View

11.

Benerini Gatta L, Albertini A, Ravid R, Finazzi D . Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport. 2002; 13(16):2031-3. DOI: 10.1097/00001756-200211150-00008. View

12.

Zhu X, Raina A, Rottkamp C, Aliev G, Perry G, Boux H . Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem. 2001; 76(2):435-41. DOI: 10.1046/j.1471-4159.2001.00046.x. View

13.

Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers J . MicroRNAs can regulate human APP levels. Mol Neurodegener. 2008; 3:10. PMC: 2529281. DOI: 10.1186/1750-1326-3-10. View

14.

Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

15.

Kawaji H, Severin J, Lizio M, Waterhouse A, Katayama S, Irvine K . The FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. Genome Biol. 2009; 10(4):R40. PMC: 2688931. DOI: 10.1186/gb-2009-10-4-r40. View

16.

Halazonetis T, Georgopoulos K, Greenberg M, Leder P . c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 1988; 55(5):917-24. DOI: 10.1016/0092-8674(88)90147-x. View

17.

Fellgiebel A, Kojro E, Muller M, Scheurich A, Schmidt L, Fahrenholz F . CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type. J Geriatr Psychiatry Neurol. 2008; 22(1):3-9. DOI: 10.1177/0891988708327810. View

18.

Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F . MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem. 2010; 285(24):18344-51. PMC: 2881760. DOI: 10.1074/jbc.M110.112664. View

19.

Vo N, Klein M, Varlamova O, Keller D, Yamamoto T, Goodman R . A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 2005; 102(45):16426-31. PMC: 1283476. DOI: 10.1073/pnas.0508448102. View

20.

Postina R . A closer look at alpha-secretase. Curr Alzheimer Res. 2008; 5(2):179-86. DOI: 10.2174/156720508783954668. View